CoChat

Applications and Potential of In Silico Approaches for Psychedelic Chemistry

Open access

The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.

Abstract

Molecular-level investigations of the Central Nervous System have been revolutionized by the development of computational methods, computing power, and capacity advances. These techniques have enabled researchers to analyze large amounts of data from various sources, including genomics, in vivo, and in vitro drug tests. In this review, we explore how computational methods and informatics have contributed to our understanding of mental health disorders and the development of novel drugs for neurological diseases, with a special focus on the emerging field of psychedelics. In addition, the use of state-of-the-art computational methods to predict the potential of drug compounds and bioinformatic tools to integrate disparate data sources to create predictive models is also discussed. Furthermore, the challenges associated with these methods, such as the need for large datasets and the diversity of in vitro data, are explored. Overall, this review highlights the immense potential of computational methods and informatics in Central Nervous System research and underscores the need for continued development and refinement of these techniques and more inclusion of Quantitative Structure-Activity Relationships (QSARs).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/molecules28165966

Cites

99 of 99 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 A general overview of monoamine transportation.
Figure 1 A general overview of monoamine transportation.CC BY · PubMed Central
Figure 2 Timeline of key events in computational psychedelic sciences [20,21].
Figure 2 Timeline of key events in computational psychedelic sciences [20,21].CC BY · PubMed Central
Figure 3 The purple dashed line represents the total number of publication hits, for 2015–2022, on Scopus for studies that also contained one or more of the terms “CNS”, “serotonin”, “dopamine”, or “norepinephrine” as of 20 March 2023 (right ordinate). Each column, within a given year, indicates the number of publications (within the same above search criteria, left ordinate) that also include the related in silico terms “Computational”, “DFT”, “Molecular Dynamics”, and/or “QSAR”.
Figure 3 The purple dashed line represents the total number of publication hits, for 2015–2022, on Scopus for studies that also contained one or more of the terms “CNS”, “serotonin”, “dopamine”, or “norepinephrine” as of 20 March 2023 (right ordinate). Each column, within a given year, indicates the number of publications (within the same above search criteria, left ordinate) that also include the related in silico terms “Computational”, “DFT”, “Molecular Dynamics”, and/or “QSAR”.CC BY · PubMed Central
Figure 4 A multi-scale computational approach is generally used for enzyme mechanism studies.
Figure 4 A multi-scale computational approach is generally used for enzyme mechanism studies.CC BY · PubMed Central
Figure 5 Metabolic degradation of histamine (HIS) to the corresponding aldehyde by MAO, but only after HIS is converted to N-methylhistamine (NMH) with histamine methyltransferase (HMT).
Figure 5 Metabolic degradation of histamine (HIS) to the corresponding aldehyde by MAO, but only after HIS is converted to N-methylhistamine (NMH) with histamine methyltransferase (HMT).CC BY · PubMed Central
Figure 6 Schematic illustration of two proposed mechanisms of aromatic hydroxylation of Tyramine by Cpd 1, as proposed via (a) a Meisenheimer-complex mechanism and (b) a radical [65,66].
Figure 6 Schematic illustration of two proposed mechanisms of aromatic hydroxylation of Tyramine by Cpd 1, as proposed via (a) a Meisenheimer-complex mechanism and (b) a radical [65,66].CC BY · PubMed Central
Figure 7 The molecular structures, showing their stereoisomers, of several important cathinones and amphetamine analogs (R-MDMA docked within the central binding site of SERT) are provided in Figure S1.
Figure 7 The molecular structures, showing their stereoisomers, of several important cathinones and amphetamine analogs (R-MDMA docked within the central binding site of SERT) are provided in Figure S1.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 2

  1. Shulgin A.T. Psychotomimetic Drugs: Structure-Activity Relationships Iversen L.L. Iversen S.D. Snyder S.H. Springer Boston, MA, USA 1978 978-1-4757-0510-2
  2. Gad S.C. QSAR Encyclopedia of Toxicology 3rd ed. Elsevier Inc. Amsterdam, The Netherlands 2014 Volume 4 1 9 9780123864543

Cited by

See all 8

Metadata

Authors
Karabulut, S., Kaur, H., & Gauld, J. W.
Affiliations
  • University of Windsor (CA)
  • Pharmala Biotech, 82 Richmond Street E, Toronto, ON M5C 1P1, Canada
Corresponding author
Gauld, James W.
Venue
Molecules
Publisher
MDPI AG
Published
2023-08-09
Volume
28
Issue
16
Pages
5966
ISSN
1420-3049 (ISSN-L)
OpenAlex
W4385697551
Cited by
8
References
99
Citations by year
2026: 4 · 2025: 1 · 2024: 3
FWCI
0.14
Type
journal article
Language
en
Open access
Locations
  • Molecules (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Scholarship at UWindsor (University of Windsor) (submittedVersion)
Funders
  • Natural Sciences and Engineering Research Council (NSERC) of Canada (04840-2018, IT29298)
  • MITACS (04840-2018, IT29298)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Physical Sciences › Materials Science › Materials Chemistry › Machine Learning in Materials Science
Keywords
psychedelics, computational drug discovery, computational chemistry, central nervous system, mental illness, neurological disorders, drug prediction, bioinformatics, prediction model, QSAR
MeSH terms
Central Nervous System, Drug Compounding, Hallucinogens, Computational Biology, Genomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.